Kidney Stone Management Market Size & Growth Forecast 2027–2036, By Segments (Treatment, End-use, Type, Diagnostics), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Kidney Stone Management Market size was around USD 3.01 Billion in 2026 and is slated to grow at 5.29% CAGR from 2027 to 2036, attaining USD 5.04 Billion by 2036. The industry revenue for 2027 is estimated at USD 3.14 Billion.
Get more details on this report
Request Free Sample ReportKidney Stone Management Market Intelligence Snapshot
Regional Market Dynamics
- North America led in 2026 due to advanced urological infrastructure, high healthcare expenditure, and strong adoption of minimally invasive treatment technologies.
- Asia Pacific is the fastest-growing region, supported by improving healthcare infrastructure, rising awareness, expanding urological access, and greater adoption of minimally invasive procedures.
Segment Momentum
- ESWL accounted for 61.69% of the market in 2026 because its non-invasive approach, shorter recovery time, and broad suitability for treating appropriately sized stones make it a preferred treatment option.
- Ambulatory surgical centers are the fastest-growing end-use segment as minimally invasive procedures increasingly shift to cost-efficient outpatient settings that enable faster treatment, recovery, and same-day care.
Market Expansion Drivers
- Increasing kidney stone recurrence rates driving demand for advanced minimally invasive treatments
- Favourable reimbursement policies supporting wider adoption of lithotripsy and urological procedures
- Rising awareness of preventive kidney health driving early diagnosis and treatment adoption
Leading Market Participants
- Key companies in the kidney stone management market include Boston Scientific Corporation (United States), Olympus Corporation (Japan), KARL STORZ SE & Co. KG (Germany), Cook Medical Incorporated (United States), Dornier MedTech GmbH (Germany), EMS Electro Medical Systems S.A. (Switzerland), Siemens Healthineers AG (Germany), Richard Wolf GmbH (Germany), Medispec Ltd. (Israel), DirexGroup Ltd. (Israel)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 3.01 Billion
- 2027 Estimated Market Size: USD 3.14 Billion
- Projected Market Size: USD 5.04 Billion by 2036
- Growth Forecast: 5.29% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Extracorporeal Shock Wave Lithotripsy (ESWL) (Treatment) | Hospitals (End-use) | Calcium Oxalate (Type) | Computed Tomography (Diagnostics)
- Emerging Opportunity Segment: Ureteroscopy (Treatment) | Ambulatory Surgical Centers (End-use) | Uric Acid (Type) | Computed Tomography (Diagnostics)
Market Growth Drivers and Industry Trends
Increasing kidney stone recurrence rates driving demand for advanced minimally invasive treatments
Rising cases of recurring kidney stone conditions are increasing the need for effective treatment approaches, which will drive the kidney stone management market growth through greater adoption of advanced minimally invasive procedures. Patients and healthcare providers are increasingly focusing on solutions that reduce procedural burden while improving treatment outcomes. Technologies such as lithotripsy and other minimally invasive interventions are gaining importance as they offer targeted management options compared with more invasive surgical approaches.
Favourable reimbursement policies supporting wider adoption of lithotripsy and urological procedures
Improved reimbursement coverage for kidney stone treatments is expanding patient access to diagnostic and therapeutic procedures, strengthening the kidney stone management market growth. Supportive healthcare payment frameworks encourage hospitals and clinics to invest in advanced urological equipment while reducing financial barriers for patients requiring specialized interventions. This environment enables broader utilization of procedures such as lithotripsy and other established treatment methods across healthcare facilities.
Rising awareness of preventive kidney health driving early diagnosis and treatment adoption
Growing public awareness regarding kidney health and preventive care is increasing patient engagement with early screening and medical consultation, supporting the kidney stone management market demand. Individuals are becoming more attentive to symptoms, lifestyle factors, and recurrence prevention strategies, leading to earlier detection and timely intervention. Healthcare providers are also emphasizing preventive approaches that combine diagnosis, monitoring, and treatment planning to manage kidney stone conditions more effectively.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing kidney stone recurrence rates driving demand for advanced minimally invasive treatments | 2% | High | North America, Europe | High | Near Term |
| Favourable reimbursement policies supporting wider adoption of lithotripsy and urological procedures | 1.7% | High | North America, Europe | High | Near Term |
| Rising awareness of preventive kidney health driving early diagnosis and treatment adoption | 1.6% | Moderate | Asia Pacific, Latin America | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held the largest position in the kidney stone management market in 2026, supported by advanced urological care infrastructure, strong access to minimally invasive treatment technologies, and high healthcare expenditure. Growing awareness of kidney stone symptoms and treatment options is encouraging timely diagnosis and intervention, while the availability of sophisticated imaging and surgical techniques is supporting effective disease management. Increasing prevalence of lifestyle-related risk factors and continued investment in specialized healthcare services are further sustaining regional demand.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is anticipated to experience the fastest growth, driven by improving healthcare infrastructure, expanding access to urological services, and rising awareness of kidney stone diagnosis and treatment. Urbanization and changing dietary patterns are contributing to greater demand for preventive and therapeutic care, while increasing healthcare investment is enabling hospitals and specialty centers to adopt advanced treatment technologies. The growing availability of minimally invasive procedures is also improving treatment accessibility across developing healthcare markets in the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
United States 🇺🇸
Advanced Treatment AdoptionThe U.S. kidney stone management market emphasizes minimally invasive procedures, digital imaging integration, and outpatient care pathways. Healthcare providers continue investing in advanced laser lithotripsy systems and flexible ureteroscopy technologies to improve procedural efficiency and patient recovery.
Germany 🇩🇪
Precision Clinical PracticeGermany prioritizes evidence-based kidney stone management supported by advanced endourology capabilities and hospital modernization. The country's focus on high-quality surgical outcomes encourages continued adoption of precise stone fragmentation technologies and optimized treatment workflows.
Japan 🇯🇵
Aging Care IntegrationJapan aligns kidney stone management with the needs of its aging population by emphasizing less invasive interventions and efficient hospital care. Healthcare institutions increasingly integrate advanced endoscopic equipment to support accurate diagnosis and streamlined treatment pathways.
South Korea 🇰🇷
Technology-Driven UrologySouth Korea strengthens kidney stone management through rapid adoption of innovative urological devices and modern surgical infrastructure. The country supports wider use of advanced laser platforms and image-guided procedures that improve procedural precision and patient convenience.
France 🇫🇷
Hospital Care OptimizationFrance focuses on optimizing kidney stone management through standardized hospital protocols and broader access to minimally invasive procedures. Clinical priorities include improving treatment efficiency while reducing patient hospitalization and post-procedure recovery time.
Italy 🇮🇹
Specialized Urology ServicesItaly continues expanding specialized urology services that support effective kidney stone management across regional healthcare facilities. Clinical adoption increasingly favors minimally invasive technologies that enhance treatment accuracy while improving patient outcomes and procedural efficiency.
Segment Leadership and Growth Trends
Kidney Stone Management Market Share (%), by Treatment, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportTreatment Segment Analysis: Extracorporeal Shock Wave Lithotripsy (ESWL) (Largest Segment) vs Ureteroscopy (Fastest-Growing Segment)
Extracorporeal shock wave lithotripsy (ESWL) dominated the kidney stone management market with a share of 61.69% in 2026 owing to its non-invasive nature, reduced recovery time, and broad suitability for treating appropriately sized kidney stones. The procedure minimizes surgical intervention while enabling effective stone fragmentation, making it a preferred treatment option for both patients and healthcare providers. Its established clinical acceptance and widespread availability continue to support its leading market position.
The ureteroscopy segment is expected to experience the fastest growth as advances in endoscopic visualization, flexible instruments, and laser-based stone fragmentation improve procedural precision and treatment outcomes. The technique is increasingly favored for complex or difficult-to-access stones while allowing high stone clearance rates with minimally invasive intervention. Growing demand for effective treatments with shorter hospital stays is contributing to expanding adoption.
End-use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)
Hospitals held the largest share of the kidney stone management market in 2026, supported by their comprehensive diagnostic capabilities, advanced surgical infrastructure, and access to multidisciplinary specialists. These facilities routinely manage complex kidney stone cases requiring sophisticated imaging, emergency care, and specialized treatment options. Their ability to provide complete patient care under one setting continues to reinforce their dominant position.
Ambulatory surgical centers are projected to be the fastest-growing segment as healthcare systems increasingly shift suitable minimally invasive procedures toward cost-efficient outpatient environments. Improved procedural technologies and streamlined clinical workflows enable faster treatment and recovery while reducing hospitalization requirements. Rising patient preference for convenient, same-day procedures is expected to strengthen segment growth.
Type Segment Analysis: Calcium Oxalate (Largest Segment) vs Uric Acid (Fastest-Growing Segment)
The calcium oxalate segment led the kidney stone management market in 2026, reflecting the high prevalence of this stone type among affected patients. Its widespread occurrence has driven continuous demand for diagnostic procedures, preventive strategies, and treatment approaches specifically tailored to calcium oxalate stone management. Greater awareness regarding dietary management and recurrence prevention also supports sustained clinical focus on this segment.
The uric acid segment is anticipated to record the fastest growth owing to increasing recognition of metabolic risk factors and the availability of targeted treatment approaches. Improved diagnostic methods are enabling earlier identification of uric acid stones, while growing emphasis on individualized management strategies is encouraging wider adoption of appropriate therapeutic interventions. Continued focus on preventive care is expected to further support this segment's expansion.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Treatment | Extracorporeal Shock Wave Lithotripsy (ESWL), Ureteroscopy, Percutaneous Nephrolithotomy (PCNL), Others | Extracorporeal Shock Wave Lithotripsy (ESWL) | Ureteroscopy |
| End-use | Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others | Hospitals | Ambulatory Surgical Centers |
| Type | Calcium Oxalate, Calcium Phosphate, Uric Acid, Struvite, Cysteine | Calcium Oxalate | Uric Acid |
| Diagnostics | Abdominal X-ray, Computed Tomography, Ultrasound, Abdominal MRI, Intravenous Pyelography, Others | Computed Tomography | Computed Tomography |
Competitive Landscape and Market Positioning
Prominent players in the kidney stone management market:
- Boston Scientific Corporation (United States)
- Olympus Corporation (Japan)
- KARL STORZ SE & Co. KG (Germany)
- Cook Medical Incorporated (United States)
- Dornier MedTech GmbH (Germany)
- EMS Electro Medical Systems S.A. (Switzerland)
- Siemens Healthineers AG (Germany)
- Richard Wolf GmbH (Germany)
- Medispec Ltd. (Israel)
- DirexGroup Ltd. (Israel)
The kidney stone management market is evolving through competition centered on improving treatment precision, patient outcomes, and procedural efficiency. Medical technology providers are increasingly differentiating through solutions that enable less invasive interventions, enhanced diagnostic capabilities, and more effective management of complex cases. Healthcare systems are placing greater emphasis on reducing procedure burden and improving recovery experiences, pushing market participants to advance technologies that support faster and more predictable treatments. The competitive landscape is also shaped by the need for solutions that integrate seamlessly into clinical workflows while addressing the growing demand for specialized urological care.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Boston Scientific Corporation (United States) | |||||||
| Olympus Corporation (Japan) | |||||||
| KARL STORZ SE & Co. KG (Germany) | |||||||
| Cook Medical Incorporated (United States) | |||||||
| Dornier MedTech GmbH (Germany) | |||||||
| EMS Electro Medical Systems S.A. (Switzerland) | |||||||
| Siemens Healthineers AG (Germany) | |||||||
| Richard Wolf GmbH (Germany) | |||||||
| Medispec Ltd. (Israel) | |||||||
| DirexGroup Ltd. (Israel) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Biorad Medisys | Jun-26 | Biorad Medisys commercialized the Quantino 20W Thulium Fiber Laser System for kidney stone management. The launch introduces a highly compact laser solution that improves surgical access and expands treatment delivery options for advanced urological stone procedures. |
| Ventaris Surgical, Inc. | Jan-26 | Ventaris Surgical, Inc. secured $30 million in a Series A financing round led by Longitude Capital. The capital injection will fund the development of a proprietary ureteroscopic system designed to achieve complete stone clearance and improve clinical outcomes in minimally invasive urological procedures. |
| Ambu | Jun-25 | Ambu secured U.S. FDA clearance for its aScope 5 Cysto HD, marking the first single-use flexible cysto-nephroscope approved in the United States. This regulatory milestone scales the adoption of advanced disposable endoscopic systems for complex kidney stone management workflows. |
| Olympus | Apr-24 | Olympus obtained U.S. FDA 510(k) clearance for its RenaFlex single-use digital ureteroscope system. The single-use platform provides high-precision visualization and access to the urinary tract, mitigating cross-contamination risks during minimally invasive therapeutic interventions for kidney stones. |
| Boston Scientific | Feb-23 | Boston Scientific received U.S. FDA 510(k) clearance for its LithoVue Elite Single-Use Digital Flexible Ureteroscope System. The innovation integrates real-time intrarenal pressure monitoring directly into the device, enhancing safety margins and precision during single-use retrograde intrarenal surgeries. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Kidney Stone Management Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Stone Size | Less Than 5 mm, 5–10 mm, Greater Than 10 mm |
| Stone Location | Kidney, Ureter, Multiple Locations |
| Patient Age Group | Pediatric, Adult, Geriatric |
Kidney Stone Management Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| Treatment Pathway Optimization |
|
| Minimally Invasive Procedure Adoption |
|
| Patient Access & Care Gaps |
|
Need a different cut of the data?
Request Custom ResearchWhat is the market valuation of kidney stone management?
What are the growth projections for the kidney stone management industry?
How are minimally invasive treatment trends influencing the kidney stone management market?
Why are reimbursement policies and preventive awareness supporting market expansion?
Why is Extracorporeal Shock Wave Lithotripsy (ESWL) the leading treatment for kidney stones?
Which end-use segment is growing the fastest in the kidney stone management market?
Why does North America lead the kidney stone management market?
How is Asia Pacific shaping future market growth?
Which companies dominate the kidney stone management landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization